Combined chemical-enzymatic assembly of aminoglycoside derivatives with N-1-AHB side chain

Advanced Synthesis and Catalysis

Volumn 350, Issue 11-12, 2008, Pages 1682-1688

  Nudelman, Igor ^a   Chen, Lilach ^a   Llewellyn, Nicholas M ^b   Sahraoui, El Habib ^b   Cherniavsky, Marina ^a   Spencer, Jonathan B ^b   Baasova, Timor ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aminoglycosides; Aminoglycosides toxicity; Biosynthesis of butirosin; Chemoenzymatic synthesis; Resistance to aminoglycosides; Stop codon readthrough

Indexed keywords

EID: 53849129237     PISSN: 16154150     EISSN: 15213897     Source Type: Journal    
DOI: 10.1002/adsc.200800229     Document Type: Article

References (38)

1. Q. Vicens, E. Westhof, Biopolymers 2003, 70, 42;
2. S. Magnet, J. S. Blanchard, Chem. Rev. 2005, 105, 477.
3. G. D. Wright, A. M. Berghuis, S. Mobashery, Adv. Exp. Med. Biol. 1998, 456, 27.
4. E. Selimoglu, Curr. Pharm. Des. 2007, 13, 119.
5. a) W. A. Greenberg, E. S. Priestley, P. S. Sears, P. B. Alper, C. Rosenbohm, M. Hendrix, S. C. Hung, C. H. Wong, J. Am. Chem. Soc. 1999, 121, 6527;
6. b) F. Agnelli, S. J. Sucheck, K. A. Marby, D. Rabuka, S. L. Yao, P. S. Sears, F. S. Liang, C. H. Wong, Angew. Chem. 2004, 116, 1588;
7. Angew. Chem. Int. Ed. 2004, 43, 1562;
8. c) J. Li, C. W. Chang, Anti-Infect. Agents Med. Chem. 2006, 5, 255;
9. d) J. Zhou, G. Wang, L. H. Zhang, X. S. Ye, Med. Res. Rev. 2007, 27, 279.
10. a) H. Kawaguchi, T. Naito, S. Nakagawa, K. I. Fujisawa, J. Antibiot. (Tokyo) 1972, 25, 695;
11. b) D. Ikeda, T. Tsuchiya, S. Umezawa, H. Umezawa, J. Antibiot. 1972, 25, 741;
12. c) S. Kondo, K. Iinuma, H. Yamamoto, K. Maeda, H. Umezawa, J. Antibiot. (Tokyo) 1973, 26, 412;
13. d) S. Kondo, K. Iinuma, H. Yamamoto, Y. Ikeda, K. Maeda, J. Antibiot. (Tokyo) 1973, 26, 705;
14. e) S. H. Lee, C. S. Cheong, Tetrahedron Lett. 2001, 42, 4801-4815;
15. f) R. Rai, H. N. Chen, P. G. Czyryca, J. Li, C. W. Chang, Org. Lett. 2006, 8, 887;
16. g) J. Li, F. I. Chiang, H. N. Chen, C. W. Chang, J. Org. Chem. 2007, 72, 4055;
17. h) S. H. E. Swayze, J. Szychowski, S. S. Adhikari, K. Pachamuthu, X. Wang, M. T. Migawa, R. H. Griffey, (Isis Pharmaceuticals Inc), PCT WO2007064954, 2007.
18. J. D. Howells, L. E. Anderson, G. L. Coffey, G. D. Senos, M. A. Underhill, D. L. Vogler, J. Ehrlich, Antimicrob. Agents Chemother. 1972, 2, 79.
19. K. Fujisawa, T. Hoshiya, H. Kawaguchi, J. Antibiot. (Tokyo) 1974, 27, 677.
20. S. Kondo, K. Hotta, J. Infect. Chemother. 1999, 5, 1.
21. J. Kondo, B. Francois, R. J. Russell, J. B. Murray, E. Westhof, Biochimie 2006, 88, 1027.
22. a) J. Kondo, K. Pachamuthu, B. Francois, J. Szychowski, S. Hanessian, E. Westhof, ChemMedChem 2007, 2, 1631;
23. b) R. J. Russell, J. B. Murray, G. Lentzen, J. Haddad, S. Mobashery, J. Am. Chem. Soc. 2003, 125, 3410;
24. c) J. B. Murray, S. O. Meroueh, R. J. Russell, G. Lentzen, J. Haddad, S. Mobashery, Chem. Biol. 2006, 13, 129.
25. J. Haddad, L. P. Kotra, B. Llano-Sotelo, C. Kim, E. F. Azucena, M. Z. Liu, S. B. Vakulenko, C. S. Chow, S. Mobashery, J. Am. Chem. Soc. 2002, 124, 3229.
26. a) J. F. Burke, A. E. Mogg, Nucleic Acids Res. 1985, 13, 6265;
27. b) R. J. Kaufman, J. Clin. Invest. 1999, 104, 367;
28. c) M. Manuvakhova, K. Keeling, D. M. Bedwell, RNA 2000, 6, 1044;
29. d) E. Kerem, Curr. Opin. Pulm. Med. 2004, 10, 547;
30. e) M. Hainrichson, I. Nudelman, T. Baasov, Org. Biomol. Chem. 2008, 6, 227.
31. I. Nudelman, A. Rebibo-Sabbah, D. Shallom-Shezifi, M. Hainrichson, I. Stahl, T. Ben-Yosef, T. Baasov, Bioorg. Med. Chem. Lett. 2006, 16, 6310.
32. A. Rebibo-Sabbah, I. Nudelman, Z. M. Ahmed, T. Baasov, T. Ben-Yosef, Hum. Genet. 2007, 122, 373.
33. L. Chen, M. Hainrichson, D. Bourdetsky, A. Mor, S. Yaron, T. Baasov, in preparation/revision.
34. N. M. Llewellyn, Y. Li, J. B. Spencer, Chem. Biol. 2007, 14, 379.
35. N. M. Llewellyn, J. B. Spencer, Chem. Commun. 2008, DOI; 10.1039/B802248H.
36. 3N) afforded the acyl migration product from the 6 position to N-1 amine as a main product (75%). To avoid this limitation, 17 was first converted to the corresponding 6-hydroxy compound 19 in two successive steps (78%), which after the same two steps for the installation of AHB followed by treatment with methylamine and the Staudinger reaction furnished the desired product NB54 bearing the AHB moiety at the N-1 position.
37. H. A. Kirst, B. A. Truedell, J. E. Toth, Tetrahedron Lett. 1981, 22, 295.
38. G. Grentzmann, J. A. Ingram, P. J. Kelly, R. F. Gesteland, J. F. Atkins, Rna 1998, 4, 479.